8-K: TriSalus Life Sciences Changes Auditors, Appoints Grant Thornton After Dismissing KPMG

TriSalus Life Sciences has dismissed KPMG as its independent auditor and appointed Grant Thornton, citing no disagreements on accounting principles but acknowledging material weaknesses in internal controls.

Summary

• TriSalus Life Sciences dismissed KPMG as their independent auditor on April 12, 2024.
• The dismissal was approved by the Audit Committee of the Board of Directors.
• KPMG's audit reports for the years ended December 31, 2023 and 2022, did not contain any adverse opinions or disclaimers, but included a going concern paragraph due to recurring losses and the need for additional funding.
• There were no disagreements with KPMG on accounting principles or practices, but material weaknesses in internal controls were identified.
• These weaknesses included a lack of trained resources, inadequate controls over accounting for a Standby Equity Purchase Agreement, patent costs, research and development accruals, the business combination, and the valuation of warrants and equity awards.
• Grant Thornton LLP was appointed as the new independent auditor on April 12, 2024, effective after KPMG's dismissal.
• TriSalus did not consult with Grant Thornton on accounting principles or audit opinions prior to their appointment.

Sentiment

Score: 3

Explanation: The document highlights significant financial concerns, including a going concern issue and material weaknesses in internal controls, leading to a negative sentiment.

Positives

• The company has taken action to address the going concern issue by seeking additional funding.
• The company has appointed a new auditor, Grant Thornton, which may bring fresh perspectives and expertise.
• There were no disagreements with the previous auditor, KPMG, on accounting principles or practices.

Negatives

• KPMG's audit reports included a going concern paragraph, indicating financial instability.
• Material weaknesses in internal controls were identified, which could lead to financial reporting errors.
• The company has suffered recurring losses from operations and needs to raise additional equity or debt to fund its operations.

Risks

• The company's ability to continue as a going concern is in doubt due to recurring losses and the need for additional funding.
• Material weaknesses in internal controls could lead to inaccurate financial reporting and potential regulatory issues.
• The change in auditors could create uncertainty and require additional time for the new auditor to become familiar with the company's financials.

Future Outlook

The company needs to raise additional equity or debt to fund its operations, as stated in the going concern paragraph of the audit report.

Management Comments

• Management's plans regarding the going concern issue are described in Note 1 to the consolidated financial statements.

Industry Context

Changes in auditors are not uncommon, but the going concern issue and material weaknesses in internal controls raise concerns about the company's financial health compared to industry peers.

Comparison to Industry Standards

• The going concern qualification in the audit report is a significant concern, as it indicates a higher level of financial risk than is typical for publicly traded companies.
• The identified material weaknesses in internal controls are also a concern, as they suggest a lack of robust financial oversight compared to companies with mature financial reporting systems.
• Companies like Medtronic or Boston Scientific, which are established medical device companies, typically have more robust internal controls and do not have going concern issues.

Stakeholder Impact

• Shareholders may be concerned about the company's financial stability and the going concern issue.
• Employees may be concerned about the company's ability to continue operations.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company needs to address the material weaknesses in internal controls.
• The company needs to secure additional funding to continue operations.

Key Dates

Keywords

auditor, KPMG, Grant Thornton, internal controls, financial reporting, going concern, accounting, audit, material weakness